ArticleJournal of computer-aided molecular design2025
Therapeutic potency of a developed optimized polyherbal formulation in ameliorating obesity induced inflammation and oxidative stress in Swiss albino mice by targeting PPARγ, insulin receptor and AMPK signalling pathway.
Article in Journal of computer-aided molecular design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The context-dependent roles of PPAR-γ in adipocyte differentiation and obesity: a master regulator with dual functions.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High fat diet (HFD) induced obesity plays a key role in onset of inflammation, a chronic response of the body to elevated expression of proinflammatory cytokines. Our work emphasized on assessing the therapeutic potency of the polyherbal formulations (PHF), composed of Phyllanthus urinaria and Adhatoda vascia nees by studying the expression pattern of iNOS, pro, anti-inflammatory cytokines, chemokine along with identification of potent anti-inflammatory compounds in HFD induced inflammation in four weeks old (23-25 g bw, n = 6 in triplcates) Swiss albino mice. The findings demonstrated high percentage of free radical scavenging property of PHF, downregulation of expression level of proinflammatory cytokines and chemokines, profound elevation of anti-inflammatory cytokines, anti-oxidant enzymes in both PHF treated groups signifying protection against oxidative stress. In silico study revealed binding energy of Okanin, Vomicine, Granisetron and Pisdic acid - 9.31 kcal/mol, - 8.34 kcal/mol, - 8.10 kcal/mol, - 7.93 kcal/mol respectively with strong protein ligand interaction with inflammatory, lipid marker PPARγ and insulin resistance marker protein receptor INSR. Among other four ligands, Peganine, Coralyne, Soraphen O and 2-hydroxyhexadecanoic acid; Soraphen O and Coralyne showed best binding affinity with INSR (- 6.8 kcal/mol) and PPARγ (- 6.9 kcal/mol) respectively. The evaluation based on network pharmacology, the active ingredients of the PHF for AMPK signalling pathway and protein analysis identified 121 targets. A network of interaction between the eight ligands and known therapeutic targets of INSR and AMPK depicted pharmacological mechanisms of the PHF in inhibition of insulin resistance by activating INSR and AMPK-pathway thus establishing itself as potent alternative drug in treating ailments associated with obesity induced inflammation.
Indexed as
Identifiers
40660051What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.